Dominari Holdings Inc.

Dominari Holdings Inc. is a holding company engaged in wealth management, investment banking, sales and trading, asset management, and insurance through its subsidiaries. The company also provides management support to its subsidiaries' executive teams to enhance operational efficiency and reduce costs. Dominari Financial Inc., a wholly owned subsidiary, drives the company's growth strategy in the financial services industry, pursuing both organic growth and acquisitions of third-party financial assets like registered investment advisors, broker-dealers, asset management firms, fintech firms, and insurance brokers. On March 27, 2023, Dominari Financial acquired 100% of a dually registered broker-dealer and investment advisor from Fieldpoint Private Bank & Trust, which was subsequently renamed Dominari Securities LLC and operates as a wholly owned subsidiary of Dominari Financial. Dominari Holdings Inc., founded in 1967 as Spherix Incorporated and formerly known as AIkido Pharma, Inc., operated as a biotechnology company since 2017 with a portfolio of small-molecule anticancer and antiviral therapeutics. The company is currently winding down its historical biotechnology assets held by Dominari Labs, LLC. In June 2022, Dominari Holdings Inc. formed Dominari Financial Inc. to shift its primary operating focus to the fintech and financial services industries. Dominari Securities LLC, acquired through Dominari Financial, is an introducing broker-dealer, a member of FINRA, and an investment adviser registered with the SEC.